- Home
- Our company
- Social impact
- Global health equity
- Improving access to care and services
Improving access to care and services
        We collaborate with public and private sector organizations to expand access to care and services to improve global health.
    
            
        Featured stories
Janssen, the Pharmaceutical Companies of Johnson & Johnson, Announces First-of-its-Kind Drug Donation Program for HIV Treatment-Experienced Children
        Sub-Saharan African Ministries of Health Invited to Submit Expression of Interest to Participate in New EffortDonation Program to be Part of Broader Initiative to Raise Awareness and Action
    
        
    
    Johnson & Johnson secures a top spot on the 2016 Access to Medicine Index
        The index looks at companies that do the best job of providing access to medications in developing countries. Johnson & Johnson ranked #2—and here’s why. 
    
        
    
    More from Johnson & Johnson
Juvenile myasthenia gravis: Inside one adolescent’s journey
        The condition is typically diagnosed in adults, but research suggests an uptick in adolescent patients. Learn more about the rare autoantibody disease, how one teen is managing it and why Johnson & Johnson is working to improve treatment options for patients of all ages.
    
        
    
    5 ways Johnson & Johnson is innovating in medicines and therapies
        From rare diseases to all-too-common cancers, Johnson & Johnson is on a mission to improve treatment options for people around the globe. Learn more about how the company is working to create new therapies for IBD, lung cancer, major depressive disorder, bladder cancer, myasthenia gravis and more. 
    
        
    
    Johnson & Johnson to collaborate with the New York Jets to promote better health in the community
        Teaming up to support healthcare in the local community and empower residents.
    
        
    
     
 
 
 
 
 
 
